🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Biological therapies use different ways to stimulate the immune ...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
1997-02
Trial ID
NCT00004604
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Status
Completed
Location
Medicine Branch
Start Date
1996-02
Trial ID
NCT00019084
This phase II, randomized, open-label trial aims to assess whether the vacc...
Status
Terminated
Location
UO Immunoterapia e laboratorio TCS, IRST IRCCS
Start Date
2015-08
Trial ID
NCT02718391
Treatments Being Tested
Despite recent advances in the treatment of patients with resected NSCLC, d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01398124
Treatments Being Tested
This study is for subjects with a type of skin cancer called melanoma. The ...
Status
Terminated
Location
Medical University of South Carolina
Start Date
2012-10
Trial ID
NCT01783431
Treatments Being Tested
In this study, a melanoma vaccine (5 melanoma peptides) is given with eithe...
Status
Completed
Location
NYU Clinical Cancer Center
Start Date
2005-07
Trial ID
NCT00124124
Treatments Being Tested
RATIONALE: Vaccines made from a person's tumor cells and white blood cells ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2001-01
Trial ID
NCT00023985
Treatments Being Tested
Background: * Pediatric solid tumors (Ewing's sarcoma, rhabdomyosarcoma, a...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-06-02
Trial ID
NCT00923351
The purpose of this study is to test the safety and effects of a special ty...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2014-01-08
Trial ID
NCT02010606
The purpose of this phase 2 study is to find the best way to give this new ...
Status
Completed
Location
University of California Los Angeles, David Geffen School of Medicine
Start Date
2009-10-13
Trial ID
NCT00910650